Application of AI in Diagnosing and Drug Repurposing in COVID 19

被引:0
作者
Ravikumar, G. K. [1 ]
Bharadwaj, Skanda [2 ]
Niveditha, N. M. [1 ]
Narendra, B. K. [1 ]
机构
[1] Adichunchanagiri Univ BGSIT, Mandya 571448, India
[2] Lambert High Sch, 805 Nichols Rd, Suwanee, GA 30024 USA
来源
ADVANCES IN ARTIFICIAL INTELLIGENCE, SOFTWARE AND SYSTEMS ENGINEERING (AHFE 2021) | 2021年 / 271卷
关键词
Artificial Intelligence; Covid-19; Drug repurposing; Diagnosing; ARTIFICIAL-INTELLIGENCE;
D O I
10.1007/978-3-030-80624-8_15
中图分类号
TP18 [人工智能理论];
学科分类号
081104 ; 0812 ; 0835 ; 1405 ;
摘要
Corona virus is a type of virus. We can find diverse kinds of Corona viruses among them only few of them cause disease and when they cause disease, it would be cold and other mild respiratory illness. However, couple of corona viruses causes severe diseases like (MERS) Middle East respiratory syndrome and (SERS) Severe Acute Respiratory Syndrome. Scientists identified this virus as the cause of a disease outbreak inWuhan, China inDecember 2019. This virus is identified as (SARS-CoV-2) Severe Acute Respiratory Syndrome Corona Virus 2. The disease is well known as COVID-19. Corona virus is declared as an outbreak pandemic on 11 March 2020 by World Health Organization (WHO). Via biomedical exploration, clinical science, precision medicine and medical diagnostics/devices, Artificial Intelligence (AI) is quickly becoming an important approach. These tools will discover a new ways for researchers, clinicians, and patient, helping to make choices that are educated and to produce better results. These methods have the potential to increase the efficacy and efficiency of health research and treatment ecosystem when applied in healthcare environments, and potentially improve the quality of patient care. Today in this world of AI and network medicine which will give us application of information science. In this work we have discussed about how we are utilizing this new trend of AI in drug repurposing during this pandemic situation.
引用
收藏
页码:116 / 124
页数:9
相关论文
共 20 条
[1]  
[Anonymous], ABOUT US, DOI DOI 10.1039/B820528K
[2]  
Chowdhury Muhammad E. H., 2020, IEEE Access, V8, DOI [10.1109/ACCESS.2020.3010287, DOI 10.1109/ACCESS.2020.3010287]
[3]  
Fang C, 2020, medRxiv, DOI [10.1101/2020.03.20.20037325, 10.1101/2020.03.20.20037325, DOI 10.1101/2020.03.20.20037325]
[4]  
Ghoshal B, 2020, Arxiv, DOI arXiv:2003.10769
[5]  
Gozes O, 2020, Arxiv, DOI [arXiv:2003.05037, DOI 10.48550/ARXIV.2003.05037]
[6]   Deep Residual Learning for Image Recognition [J].
He, Kaiming ;
Zhang, Xiangyu ;
Ren, Shaoqing ;
Sun, Jian .
2016 IEEE CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION (CVPR), 2016, :770-778
[7]  
Hochreiter S, 1997, NEURAL COMPUT, V9, P1735, DOI [10.1162/neco.1997.9.8.1735, 10.1162/neco.1997.9.1.1, 10.1007/978-3-642-24797-2]
[8]   Densely Connected Convolutional Networks [J].
Huang, Gao ;
Liu, Zhuang ;
van der Maaten, Laurens ;
Weinberger, Kilian Q. .
30TH IEEE CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION (CVPR 2017), 2017, :2261-2269
[9]  
Jin C., 2020, DEV EVALUATION AI SY, DOI [10.1101/2020.03.20.20039834, DOI 10.1101/2020.03.20.20039834]
[10]  
Jin S, 2020, medRxiv, DOI [10.1101/2020.03.19.20039354, 10.1101/2020.03.19.20039354]